HCR — Health Issues
Issues related to drug pricing, including federal proposals impacting reimbursement, access, and affordability; Issues related to Medicare Drug negotiation and implementation of the Inflation Reduction Act; Pharmacy benefit manager reform legislation; Issues related to Most Favored Nation (MFN) pricing models
Government entities lobbied: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE